At a glance

ClinicalIndex Comparison Record

N/ACompleted· 419 enrolled

Drug / intervention

Diabetes Pathwayother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02925312

NCT02925312N/ACompleted

Compare CT.gov

MedStar Pathway to Diabetes Control Demonstration Project: Type 2 Diabetes Boot Camp

Medstar Health Research Institute·interventional·Posted Oct 5, 2016·Updated Sep 23, 2020

In Brief

A clinical study evaluating Diabetes Pathway for Type 2 Diabetes Mellitus and Hyperglycemia. Completed, enrolled 419 participants across 1 site.

Detailed Summary

A Diabetes Institute (MDI), in partnership with key stakeholders-including Primary Care Providers- in a northeastern US regional, mixed-payer healthcare system), seeks to implement an evidence-based, technology-enabled, innovative, and integrated diabetes care management pathway (Boot Camp) for adult patients with uncontrolled type 2 diabetes (A1C\>/=9%) which will demonstrate improvement in diabetes clinical and health resources utilization outcomes.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsType 2 Diabetes Mellitus, Hyperglycemia

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

201520162017201820192020202120222023202420252026

Enrollment StartNov 2014

Primary CompletionJun 2016

First PostedOct 2016

Study CompletionDec 2016

TodayJul 2026

First PostedOct 5, 2016

Enrollment StartNov 1, 2014

Primary CompletionJun 30, 2016

Study CompletionDec 31, 2016

TodayJul 2, 2026

Enrollment to primary: 1.7 yearsPosted 9.7 years ago

Interventions

Diabetes Pathwayother

Medication algorithm, survival skills education, enhanced patient-provider communication facilitated by near, real-time blood glucose monitoring